China Hrk Supply Raw Material Zanamivir Hydrate CAS 139110-80-8, Find details about China Zanamivir, Zanamivir Price from Hrk Supply Raw Material Zanamivir Hydrate CAS 139110-80-8
Product Name | HRK supply raw material zanamivir / Zanamivir Hydrate CAS 139110-80-8 |
Appearance | White lyophilized powder |
Assay | 99%min, 98.0% --101.0% |
Test | HPLC |
Certificate | ISO 9001 |
CAS | 139110-80-8 |
MF | C12H20N4O7 |
Storage Temperature | Cool Dry Place |
Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is aneuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings.
It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B.Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.
Product Name | CAS No. | Product Name | CAS No. |
Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |